John Wikstrand

6.1k total citations · 1 hit paper
95 papers, 4.3k citations indexed

About

John Wikstrand is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Pulmonary and Respiratory Medicine. According to data from OpenAlex, John Wikstrand has authored 95 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Cardiology and Cardiovascular Medicine, 32 papers in Endocrinology, Diabetes and Metabolism and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in John Wikstrand's work include Cardiovascular Health and Disease Prevention (27 papers), Blood Pressure and Hypertension Studies (20 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (17 papers). John Wikstrand is often cited by papers focused on Cardiovascular Health and Disease Prevention (27 papers), Blood Pressure and Hypertension Studies (20 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (17 papers). John Wikstrand collaborates with scholars based in Sweden, United Kingdom and Norway. John Wikstrand's co-authors include Inger Wendelhag, Björn Fagerberg, Tomas Gustavsson, Olov Wiklund, Johannes Hulthe, G Berglund, M Suurküla, Quan Liang, Stefan Agewall and Lena Bokemark and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

John Wikstrand

94 papers receiving 4.2k citations

Hit Papers

Ultrasound measurement of... 1991 2026 2002 2014 1991 100 200 300 400

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
John Wikstrand 2.8k 1.0k 1.0k 902 556 95 4.3k
Agostino Gnasso 1.7k 0.6× 1.0k 1.0× 1.1k 1.0× 1.1k 1.3× 467 0.8× 146 3.9k
Jeffrey T. Kuvin 3.4k 1.2× 902 0.9× 928 0.9× 1.7k 1.9× 855 1.5× 118 5.9k
Salvatore Novo 2.7k 1.0× 864 0.8× 634 0.6× 1.4k 1.6× 813 1.5× 306 5.1k
Patrick Rossignol 2.6k 0.9× 1.8k 1.7× 1.0k 1.0× 1.1k 1.2× 338 0.6× 182 5.7k
Concetta Irace 1.6k 0.6× 945 0.9× 1.2k 1.2× 992 1.1× 441 0.8× 132 3.7k
Georgios Georgiopoulos 2.4k 0.9× 529 0.5× 779 0.8× 766 0.8× 857 1.5× 270 5.2k
Stephen Pyke 1.2k 0.4× 902 0.9× 575 0.6× 928 1.0× 1.3k 2.3× 14 3.5k
Daniel L. Dries 3.8k 1.4× 787 0.8× 428 0.4× 720 0.8× 310 0.6× 56 5.0k
Marietta Charakida 1.9k 0.7× 523 0.5× 494 0.5× 698 0.8× 673 1.2× 165 4.2k
Yasufumi Doi 1.3k 0.5× 687 0.7× 1.0k 1.0× 865 1.0× 1.1k 1.9× 73 4.5k

Countries citing papers authored by John Wikstrand

Since Specialization
Citations

This map shows the geographic impact of John Wikstrand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Wikstrand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Wikstrand more than expected).

Fields of papers citing papers by John Wikstrand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Wikstrand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Wikstrand. The network helps show where John Wikstrand may publish in the future.

Co-authorship network of co-authors of John Wikstrand

This figure shows the co-authorship network connecting the top 25 collaborators of John Wikstrand. A scholar is included among the top collaborators of John Wikstrand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Wikstrand. John Wikstrand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nymo, Ståle H., Pål Aukrust, John Kjekshus, et al.. (2017). Limited Added Value of Circulating Inflammatory Biomarkers in Chronic Heart Failure. JACC Heart Failure. 5(4). 256–264. 25 indexed citations
2.
Kristensen, Søren Lund, Pardeep S. Jhund, Lars Køber, et al.. (2014). Comparison of Outcomes After Hospitalization for Worsening Heart Failure, Myocardial Infarction, and Stroke in Patients with Heart Failure and Reduced and Preserved Ejection Fraction. European Journal of Heart Failure. 17(2). 169–176. 37 indexed citations
3.
Moreno, Ana Cristina Perez, Pardeep S. Jhund, David J. Stott, et al.. (2014). Thyroid-Stimulating Hormone and Clinical Outcomes. JACC Heart Failure. 2(1). 35–40. 30 indexed citations
4.
Rogers, Jennifer K., Pardeep S. Jhund, Ana Cristina Perez Moreno, et al.. (2014). Effect of Rosuvastatin on Repeat Heart Failure Hospitalizations. JACC Heart Failure. 2(3). 289–297. 94 indexed citations
5.
Nymo, Ståle H., Johannes Hulthe, Thor Ueland, et al.. (2013). Inflammatory Cytokines in Chronic Heart Failure: Interleukin-8 is Associated with Adverse Outcome. Results from CORONA. European Journal of Heart Failure. 16(1). 68–75. 64 indexed citations
6.
Broch, Kaspar, Thor Ueland, Ståle H. Nymo, et al.. (2012). Soluble ST2 is Associated with Adverse Outcome in Patients with Heart Failure of Ischaemic Aetiology. European Journal of Heart Failure. 14(3). 268–277. 106 indexed citations
7.
Östling, Gerd, Isabel Gonçalves, John Wikstrand, et al.. (2011). Long-term treatment with low-dose metoprolol CR/XL is associated with increased plaque echogenicity: The Beta-blocker Cholesterol-lowering Asymptomatic Plaque Study (BCAPS). Atherosclerosis. 215(2). 440–445. 17 indexed citations
8.
McMurray, John J.V., Peter Dunselman, Hans Wedel, et al.. (2010). Coenzyme Q10, Rosuvastatin, and Clinical Outcomes in Heart Failure. Journal of the American College of Cardiology. 56(15). 1196–1204. 82 indexed citations
9.
Wikstrand, John. (2007). Methodological considerations of ultrasound measurement of carotid artery intima–media thickness and lumen diameter. Clinical Physiology and Functional Imaging. 27(6). 341–345. 94 indexed citations
10.
Schmidt, Caroline, et al.. (2005). apoB/apoA–I ratio is related to femoral artery plaques and is predictive for future cardiovascular events in healthy men. Atherosclerosis. 189(1). 178–185. 21 indexed citations
11.
Hulthe, Johannes, Jan Oscarsson, Gudmundur Johannsson, et al.. (2002). Intima‐media thickness in cardiovascularly asymptomatic hypopituitary adults with growth hormone deficiency: relation to body mass index, gender, and other cardiovascular risk factors. Clinical Endocrinology. 57(6). 751–759. 43 indexed citations
13.
Agewall, Stefan, John Wikstrand, & Björn Fagerberg. (1998). Prothrombin fragment 1+2 is a risk factor for myocardial infarction in treated hypertensive men. Journal of Hypertension. 16(4). 537–541. 42 indexed citations
15.
Herlitz, Hans, Bengt R. Widgren, John Wikstrand, & Mattias Aurell. (1994). Abnormalities in the renin–angiotensin–aldosterone system in normotensive subjects with a positive family history of hypertension. European Journal of Endocrinology. 131(2). 179–183. 4 indexed citations
16.
Widgren, Bengt R., G Berglund, John Wikstrand, & Ove K. Andersson. (1992). Reduced venous compliance in normotensive men with positive family histories of hypertension. Journal of Hypertension. 10(5). 459–465. 18 indexed citations
17.
Widgren, Bengt R., Hans Herlitz, Thomas Hedner, et al.. (1991). Blunted Renal Sodium Excretion During Acute Saline Loading in Normotensive Men With Positive Family Histories of Hypertension. American Journal of Hypertension. 4(7_Pt_1). 570–578. 32 indexed citations
19.
Herlitz, Hans, Marianne Hartford, Susanne Ljungman, et al.. (1988). Different patterns of cellular sodium turnover in essential hypertension. Journal of Hypertension. 6(4). S213–215. 1 indexed citations
20.
Wikstrand, John. (1988). New concepts in the treatment of elderly hypertensive patients. American Heart Journal. 116(1). 296–300. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026